lentinan has been researched along with Signet Ring Cell Carcinoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kagawa, R; Nakayama, N; Sakata, S; Tada, M; Yamaguchi, T | 1 |
| Akiba, Y; Aoki, D; Hibi, T; Ishii, H; Kato, S; Mukai, M; Naito, K; Takada, Y; Watanabe, C | 1 |
| Aoki, H; Aoki, N; Hayashi, S; Hemmi, A; Karube, H; Masuda, H; Nakayama, H; Ogame, H; Sakamoto, N; Wakabayashi, K | 1 |
| Mio, H; Terabe, K | 1 |
4 other study(ies) available for lentinan and Signet Ring Cell Carcinoma
| Article | Year |
|---|---|
[Postoperative adjuvant immunochemotherapy using Lentinan for advanced gastric carcinoma patients with metastasis in the regional lymph nodes and serosal invasion].
Topics: Adenocarcinoma; Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Cisplatin; Female; Fluorouracil; Humans; Lentinan; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Mitomycin; Neoplasm Invasiveness; Serous Membrane; Stomach Neoplasms | 2002 |
[A case of type 4 gastric cancer, diagnosed after operation for Krukenberg's tumor, treated by TS-1 plus low-dose cisplatinum].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Administration Schedule; Drug Combinations; Female; Humans; Infusions, Intravenous; Krukenberg Tumor; Lentinan; Neoplasms, Multiple Primary; Ondansetron; Ovarian Neoplasms; Oxonic Acid; Pyridines; Stomach Neoplasms; Tegafur | 2003 |
[A case of long survival with UFT and lentinan treatment in a patient with peritoneal metastasis of gastric carcinoma].
Topics: alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Signet Ring Cell; Chemotherapy, Adjuvant; Drug Administration Schedule; Drug Combinations; Female; Gastrectomy; Humans; Lentinan; Middle Aged; Neoplasm Invasiveness; Peritoneal Neoplasms; Peritoneum; Stomach Neoplasms; Survivors; Tegafur; Uracil | 2004 |
[Postoperative immunochemotherapy for gastric carcinoma with peritoneal dissemination--the effects with the combination of CDDP, 5-FU and lentinan].
Topics: Adenocarcinoma, Mucinous; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Signet Ring Cell; Cisplatin; Drug Administration Schedule; Female; Fluorouracil; Humans; Immunotherapy; Infusions, Intravenous; Injections, Intravenous; Lentinan; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Invasiveness; Peritoneal Neoplasms; Postoperative Care; Stomach Neoplasms | 1994 |